Siegel, D. S., Martin, T., Wang, M., Vij, R., Jakubowiak, A. J., Lonial, S., . . . Jagannath, S. (2012). A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. American Society of Hematology.
Citación estilo ChicagoSiegel, David S., et al. A Phase 2 Study of Single-agent Carfilzomib (PX-171-003-A1) in Patients With Relapsed and Refractory Multiple Myeloma. American Society of Hematology, 2012.
Cita MLASiegel, David S., et al. A Phase 2 Study of Single-agent Carfilzomib (PX-171-003-A1) in Patients With Relapsed and Refractory Multiple Myeloma. American Society of Hematology, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.